Pharming Group N.V. Stock price

Equities

PHARM

NL0010391025

Pharmaceuticals

Market Closed - Euronext Amsterdam 12:38:10 2024-03-28 pm EDT After market 03:37:11 pm
1.019 EUR +0.99% Intraday chart for Pharming Group N.V. 1.025 +0.59%
Sales 2023 224M 242M Sales 2024 * 262M 283M Capitalization 677M 730M
Net income 2023 -9M -9.7M Net income 2024 * 1M 1.08M EV / Sales 2023 3.08 x
Net cash position 2023 * 75.42M 81.31M Net cash position 2024 * 90.86M 97.96M EV / Sales 2024 * 2.24 x
P/E ratio 2023 *
-112 x
P/E ratio 2024 *
-336 x
Employees 332
Yield 2023 *
-
Yield 2024 *
-
Free-Float 97.91%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.69%
1 week-3.05%
Current month-1.36%
1 month-2.78%
3 months-2.87%
6 months-14.41%
Current year-1.45%
More quotes
1 week
1.00
Extreme 0.996
1.07
1 month
0.93
Extreme 0.9315
1.09
Current year
0.93
Extreme 0.9315
1.22
1 year
0.93
Extreme 0.9315
1.31
3 years
0.66
Extreme 0.6576
1.42
5 years
0.66
Extreme 0.6576
1.64
10 years
0.15
Extreme 0.15
1.64
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 08-10-12
Director of Finance/CFO 55 20-11-15
Chief Tech/Sci/R&D Officer 52 -
Members of the board TitleAgeSince
Director/Board Member 61 20-12-10
Director/Board Member 66 21-05-18
Chief Executive Officer 65 08-10-12
More insiders
Date Price Change Volume
24-03-28 1.019 +0.99% 5 288 758
24-03-27 1.009 -0.30% 7,513,826
24-03-26 1.012 -1.84% 6,155,152
24-03-25 1.031 -1.06% 3,303,648
24-03-22 1.042 -0.57% 8,267,003

Real-time Euronext Amsterdam, March 28, 2024 at 05:52 am EDT

More quotes
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The Group is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming Group N.V. serves patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia/Pacific.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.009 EUR
Average target price
2 EUR
Spread / Average Target
+98.22%
Consensus
  1. Stock
  2. Equities
  3. Stock Pharming Group N.V. - Euronext Amsterdam